Dudediligence.

Liminatus Pharma, Inc

LIMNNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Price
FilingsNewest: 8-K, Listing noticeSep 29 →InsidersNo open-market buys or sales.→Financing →PeersClosest companies: HURA, IMMX, ZSQR→

From the filings

Figures

Net income
−$12.5Mlast 12 months
Operating cash flow
−$11.8Mlast 12 months
Total debt
$1.4Mat the last balance sheet
Shares outstanding
56.0M shareson issue
Every year and quarter →